Reply to the Letter to the Editor Entitled: “The Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases”

Abstract

Get full access to this article

View all access options for this article.

References

Yayla

Karanfil

, et al. The nonalcoholic fatty liver disease and cardiovascular diseases. Angiology. 2019: 3319719863988.

Turan

. The nonalcoholic fatty liver disease fibrosis score is related to epicardial fat thickness and complexity of coronary artery disease. Angiology. 2019: 3319719844933.

Sianos

Morel

Kappetein

, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1(2):219–27.

Serruys

Kogame

Katagiri

, et al. Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study. EuroIntervention. 2019;15(3):e244–52.

Farooq

van Klaveren

Steyerberg

, et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet. 2013;381(9867):639–50.

Misumida

Ahmed

Barlow

, et al. Prognostic value of anatomical SYNTAX score and SYNTAX score II in veterans with left main and/or three-vessel coronary artery disease. Am J Cardiol. 2018;122(2):213–9.

Neumann

Sousa-Uva

Ahlsson

, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. EuroIntervention. 2019;14(14):1435–534.